Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2009
12/17/2009WO2009132093A3 Substituted arylcyclopentenes as therapeutic agents
12/17/2009US20090312546 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
12/17/2009US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009US20090312392 Amino ceramide-like compounds and therapeutic methods of use
12/17/2009US20090312375 Heterocyclic compounds, compositions comprising them and methods of their use
12/17/2009US20090312370 Macrocyclic compounds useful as bace inhibitors
12/17/2009US20090312347 Novel oxadiazole derivatives and their medical use
12/17/2009US20090312341 Cyclic amine bace-1 inhibitors having a heterocyclic substituent
12/17/2009US20090312330 Isoxazoline-substituted benzamide compound and pesticide
12/17/2009US20090312327 Pyrrolidine derivatives as nk2 receptor antagonists
12/17/2009US20090312326 Substituted imidazoles
12/17/2009US20090312325 Quinoline Derivatives As Phosphodiesterase Inhibitors
12/17/2009US20090312324 Compositions and Methods Related to RAD51 Inactivation in the Treatment of Neoplastic Diseases, and Especially CML
12/17/2009US20090312323 Compounds for the treatment of spinal muscular atrophy and other uses
12/17/2009US20090312322 Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3
12/17/2009US20090312319 Certain chemical entities, compositions and methods
12/17/2009US20090312316 Novel compounds
12/17/2009US20090312309 Novel Medicaments
12/17/2009US20090312308 Compounds and compositions as hedgehog signaling pathway modulators
12/17/2009US20090312307 Heterocyclo inhibitors of potassium channel function
12/17/2009US20090312304 Organic compounds
12/17/2009US20090312288 Kinase inhibitors
12/17/2009US20090312272 Transglutaminase inhibitors and methods of use thereof
12/17/2009US20090312260 Drug therapy for celiac sprue
12/17/2009US20090311318 Substituted (s)-benzoxazinones
12/17/2009US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
12/17/2009US20090311217 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/17/2009DE102008028071A1 Neue Cokristall-Verbindung von Rivaroxaban und Malonsäure New co-crystal compound of rivaroxaban and malonic acid
12/17/2009CA2727780A1 Novel potassium channel blockers and uses thereof
12/17/2009CA2727680A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
12/17/2009CA2727373A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
12/17/2009CA2727245A1 Imidazole derivatives useful as inhibitors of faah
12/17/2009CA2727242A1 Pyrazole derivatives useful as inhibitors of faah
12/17/2009CA2727073A1 Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
12/17/2009CA2725654A1 Imidazolidine derivatives
12/16/2009EP2133348A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
12/16/2009EP2133340A1 Novel benzazepine derivatives
12/16/2009EP2132196A1 Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
12/16/2009EP2132176A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
12/16/2009EP2131656A2 Phthalazine derivatives
12/16/2009EP1888567B1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
12/16/2009EP1576159B9 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
12/16/2009EP1390029B1 Phenylindoles for the treatment of hiv
12/16/2009CN101605783A New N, N'- 2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors
12/16/2009CN101605778A Certain substituted amides, method of making, and method of use thereof
12/16/2009CN101605776A 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors
12/16/2009CN101605767A Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
12/16/2009CN101605758A Methods for treating hepatitis C
12/16/2009CN101602741A Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
12/16/2009CN100569769C Compounds with antibacterial activity
12/16/2009CN100569759C Aryl-ureido benzoxazinone compounds
12/15/2009US7632857 Histamine H3 receptor agents, preparation and therapeutic uses
12/15/2009US7632845 Phenyl quinolines and their use as estrogenic agents
12/15/2009US7632835 2-Cyclopentyl-N-(2-bromo-6-trifluoromethyl-4-(thio)morpholin-4-yl-phenyl)-acetamide; potent openers of the KCNQ family of potassium ion channels; antiepileptic agents; anticonvulsants; anxiolytic agents; neurodegenerative disorders; analgesics for headaches, neuropathic pain; bipolar disorders
12/15/2009US7632834 Long acting beta-2-agonists and their use as medicaments
12/15/2009US7632829 Diazepan derivatives
12/15/2009CA2555454C Mycophenolate mofetil impurity
12/15/2009CA2529611C Pyrimidine derivatives for the treatment of abnormal cell growth
12/10/2009WO2009149135A1 Bis (hetero ) aryl substituted isoxazoles for use as neuronal nicotinic receptor modulators
12/10/2009WO2009148452A1 Novel 1,2,4 oxadiazole compounds and methods of use thereof
12/10/2009WO2009148403A1 Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators
12/10/2009WO2009147990A1 Novel isoxazole derivative
12/10/2009WO2009147440A1 Heterocyclic urea derivatives and methods of use thereof
12/10/2009WO2009147221A1 Small molecule leptin receptor modulators
12/10/2009WO2009147216A1 New pyridine derivatives as leptin receptor modulator mimetics
12/10/2009WO2009147211A1 New compounds v
12/10/2009WO2009146802A1 Macrocyclic urea and sulfamide derivatives as inhibitors of tafia
12/10/2009WO2009146540A1 N-piperidinyl acetamide derivatives as calcium channel blockers
12/10/2009WO2009127642A3 Use of lrrk2 inhibitors for neurodegenerative diseases
12/10/2009WO2009126003A9 Novel pyrazole and benzoxazole-substituted pyridine derivatives or pharmaceutically acceptable salts thereof, preparation process for same, and pharmaceutical composition for prevention and treatment of disorders involving aberrant cell proliferation containing same as active ingredients
12/10/2009WO2009111502A3 Anti-cancer compounds, synthesis thereof, and methods of using same
12/10/2009WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity
12/10/2009WO2008146172A3 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/10/2009WO2008135830A8 N- [6-amino-5- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain
12/10/2009US20090306389 Intermediate products for producing oxazolidinone-quinolone hybrids
12/10/2009US20090306371 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
12/10/2009US20090306145 Pyridylisoxazole Derivatives
12/10/2009US20090306134 Muscarinic receptor antagonists
12/10/2009US20090306109 Fungicide active substance combinations
12/10/2009US20090306096 Novel Isoxazoles and Methods of Use Thereof
12/10/2009US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
12/10/2009US20090306077 Novel n- (2-aminophenyl) benzamide derivative having urea structure
12/10/2009US20090306076 Morpholine Carboxamide Prokineticin Receptor Antagonists
12/10/2009US20090306075 Chemical compounds
12/10/2009US20090306072 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
12/10/2009US20090306070 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use
12/10/2009US20090306068 Novel enantiomeric pure beta agonists, manufacturing and use as a medicaments thereof
12/10/2009US20090306064 5-[4-(3-Methoxypropyl)3.4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-4 -(4-phenoxyphenyl)-piperidin-3-ol, used for treating high blood pressure, glaucoma, myocardial infarction, restenoses or stroke
12/10/2009US20090306062 2,5-Disubstituted Piperidines
12/10/2009US20090306059 Cyclic amine derivative having substituted alkyl group
12/10/2009US20090306044 Quinazoline derivatives for the treatment of cancer diseases
12/10/2009US20090306041 Inhibitors of Bruton's tyrosine kinase
12/10/2009US20090306039 Compounds and compositions as itpkb inhibitors
12/10/2009US20090306022 7-substituted tetracycline compounds
12/10/2009US20090305410 Fluorescent compounds
12/10/2009US20090304692 Triazine compounds as pi3 kinase and mtor inhibitors
12/10/2009US20090300856 Specific monocationic monochromophoric compounds of hydrazone type comprising a 2-, 4-pyridinium or 2-, 4-quinolinium unit, synthesis thereof, dye compositions containing them, and method for dyeing keratin fibres
12/10/2009CA2726925A1 Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators
12/10/2009CA2726554A1 Macrocyclic urea and sulfamide derivatives as inhibitors of tafia
12/10/2009CA2726441A1 New pyridine derivatives as leptin receptor modulator mimetics
1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 647